Oncternal Therapeutics, Inc. (ONCT) Social Stream



Oncternal Therapeutics, Inc. (ONCT): $1.13

0.01 (+0.89%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ONCT to Watchlist
Sign Up

Industry: Biotech


Ranked

of 402

in industry

ONCTERNAL THERAPEUTICS INC (ONCT) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ONCT.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-26 4 $21 $9 $15.5 $1.16 1236.21%
2022-05-06 4 $16 $9 $14 $1.16 1106.9%
2022-05-27 5 $15 $8 $12.25 $1.16 956.03%
2022-07-15 5 $15 $3.5 $10.5 $1.16 805.17%
2022-09-27 5 $15 $3.5 $10.3 $1.16 787.93%
2022-12-12 4 $15 $3.5 $9.875 $1.16 751.29%
2022-12-22 5 $15 $3.5 $8.7 $1.16 650%

The Trend in the Analyst Price Target


ONCT's average price target has moved down $6.8 over the prior 14 months.

Over the past 36 weeks, ONCT's average upside potential has been 981.01%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-09-02 5 15 3.5 10.300 1.100 836.36%
2022-09-27 5 15 3.5 10.300 0.790 1203.8%
2022-09-27 4 15 3.5 10.300 0.790 1203.8%
2022-11-04 4 15 3.5 9.875 0.905 991.16%
2022-11-07 4 15 3.5 9.875 0.890 1009.55%

ONCT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 5 0 0 0 0 5

The Trend in the Broker Recommendations


Over the past 52 weeks, ONCT's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ONCT as an investment opportunity.

  • ONCTERNAL THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 675.83% of all US stocks.
  • ONCTERNAL THERAPEUTICS INC's average analyst price target is higher than 89.6% of all US stocks.
  • ONCTERNAL THERAPEUTICS INC's variance in analysts' estimates is lower than -456.96% of stocks in the small market cap category.
  • In terms of how ONCTERNAL THERAPEUTICS INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is higher than 185.65% of that group.

Stocks similar to ONCTERNAL THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MNOV, MTEM, and SVRA.

Is ONCT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6256 seconds.